Effect of Cyclic Loading (Vibration) on Orthodontic Tooth Movement
Launched by ORTHOACCEL TECHNOLOGIES INC. · Jan 27, 2009
Trial Information
Current as of May 04, 2025
Completed
Keywords
ClinConnect Summary
This is a randomized, blinded study that will follow 32 patients for up to six months. Patients will have a minimum of 3 mm of extraction space that needs to be closed by moving the anterior teeth or canine distally. Patients will have standard orthodontic treatment and temporary anchorage devices for tooth movement and space closure. Half the patients will receive a functioning device and half the patients will receive a sham-device. Patients will use the device for 20 minutes daily; the device has a mouthpiece for the patient to lightly bite into plus a connected enclosure that stays outs...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Permanent dentition between the ages of 12 and 40
- • Minimum of 3 mm of extraction space to be closed by distal movement of all 6 anterior teeth from canine to canine or by distal movement of the canines
- • Good oral hygiene and compliance
- Exclusion Criteria:
- • Any compromised medical or dental condition
- • Patient currently involved in any other study
- • Lives significantly outside San Antonio, TX
- • use of bisphosphonates
- • pregnant females
About Orthoaccel Technologies Inc.
OrthoAccel Technologies Inc. is a leading innovator in orthodontic technology, dedicated to enhancing patient care and treatment outcomes through advanced dental solutions. The company specializes in the development and commercialization of devices that accelerate orthodontic treatment, with a focus on improving efficiency and patient comfort. By leveraging cutting-edge research and engineering, OrthoAccel aims to transform the orthodontic landscape, providing practitioners with tools that streamline processes and enhance the overall patient experience. Committed to clinical excellence, the company actively engages in clinical trials to validate the efficacy and safety of its products, ensuring they meet the highest standards of dental practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Antonio, Texas, United States
Patients applied
Trial Officials
Peter Gakunga, DDS
Principal Investigator
University of Texas Health Science Center San Antonio
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials